David Ozog, MD

Trials

Studies that name David Ozog, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:54 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT05766683 · Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines

  Henry Ford Health System · active not recruiting · Glabellar Frown Lines · principal investigator
• Ph2/Ph3
  NCT05478551 · Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

  Henry Ford Health System · active not recruiting · Scar, Hypertrophic Scar · principal investigator
• Ph2/Ph3
  NCT03887377 · The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

  Henry Ford Health System · completed · Scar, Hypertrophic Scar, Mammary Disorder · principal investigator
• N/A
  NCT00969215 · Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser

  Moy-Fincher Medical Group · completed · Scars · principal investigator
• N/A
  NCT00969475 · The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

  Moy-Fincher Medical Group · unknown · Scars · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.